MC1672A1 - Composition pour inhiber le developpement des tumeurs a base d'un derive d'acide peroxydiphosphorique - Google Patents

Composition pour inhiber le developpement des tumeurs a base d'un derive d'acide peroxydiphosphorique

Info

Publication number
MC1672A1
MC1672A1 MC851774A MC1774A MC1672A1 MC 1672 A1 MC1672 A1 MC 1672A1 MC 851774 A MC851774 A MC 851774A MC 1774 A MC1774 A MC 1774A MC 1672 A1 MC1672 A1 MC 1672A1
Authority
MC
Monaco
Prior art keywords
acid
derivative
approximately
toxic
peroxydiphosphoric
Prior art date
Application number
MC851774A
Other languages
English (en)
French (fr)
Inventor
Abdul Gaffar
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of MC1672A1 publication Critical patent/MC1672A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MC851774A 1984-06-27 1985-06-14 Composition pour inhiber le developpement des tumeurs a base d'un derive d'acide peroxydiphosphorique MC1672A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62506784A 1984-06-27 1984-06-27
US72654585A 1985-04-24 1985-04-24

Publications (1)

Publication Number Publication Date
MC1672A1 true MC1672A1 (fr) 1986-06-03

Family

ID=27089811

Family Applications (1)

Application Number Title Priority Date Filing Date
MC851774A MC1672A1 (fr) 1984-06-27 1985-06-14 Composition pour inhiber le developpement des tumeurs a base d'un derive d'acide peroxydiphosphorique

Country Status (26)

Country Link
JP (1) JPH0623108B2 (enrdf_load_html_response)
KR (1) KR880002266B1 (enrdf_load_html_response)
AT (1) AT392002B (enrdf_load_html_response)
AU (1) AU578104B2 (enrdf_load_html_response)
BE (1) BE902732A (enrdf_load_html_response)
CH (1) CH668361A5 (enrdf_load_html_response)
DE (1) DE3523263A1 (enrdf_load_html_response)
DK (1) DK168191B1 (enrdf_load_html_response)
ES (1) ES8801122A1 (enrdf_load_html_response)
FI (1) FI84697C (enrdf_load_html_response)
FR (1) FR2566665B1 (enrdf_load_html_response)
GB (1) GB2161074B (enrdf_load_html_response)
GR (1) GR851575B (enrdf_load_html_response)
IE (1) IE58434B1 (enrdf_load_html_response)
IL (1) IL75518A0 (enrdf_load_html_response)
IT (1) IT1209961B (enrdf_load_html_response)
LU (1) LU85976A1 (enrdf_load_html_response)
MA (1) MA20467A1 (enrdf_load_html_response)
MC (1) MC1672A1 (enrdf_load_html_response)
NL (1) NL8501840A (enrdf_load_html_response)
NZ (1) NZ212301A (enrdf_load_html_response)
PH (1) PH25613A (enrdf_load_html_response)
PT (1) PT80707B (enrdf_load_html_response)
SE (1) SE468501B (enrdf_load_html_response)
WO (1) WO1986000225A1 (enrdf_load_html_response)
ZW (1) ZW9585A1 (enrdf_load_html_response)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3528379A1 (de) * 1985-08-07 1987-02-12 Peter Berger Mittel zur behandlung waessriger systeme sowie zur regenerierung von koerperzellen
DE3627759A1 (de) * 1985-08-22 1987-03-19 Colgate Palmolive Co Pharmazeutische zusammensetzung zum inaktivieren bakterieller endotoxine
FR2586350B1 (fr) * 1985-08-22 1992-05-15 Colgate Palmolive Co Composition pharmaceutique a base de peroxodiphosphate pour l'inhibition de la secretion d'hormone parathyroidienne
DE4201858A1 (de) * 1992-01-24 1993-07-29 Renschler Aloys Dr Med Mittel zur behandlung maligner zellen
KR100426450B1 (ko) * 2002-03-16 2004-04-13 박래옥 구연산, 알부민 및 아연을 함유한 항암 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041149A (en) * 1976-01-12 1977-08-09 Colgate-Palmolive Company Composition and method of controlling and preventing mouth odor
US4430325A (en) * 1981-12-23 1984-02-07 Colgate-Palmolive Company Topical treatment of skin lesions

Also Published As

Publication number Publication date
NL8501840A (nl) 1986-01-16
DK248085A (da) 1985-12-28
SE468501B (sv) 1993-02-01
LU85976A1 (fr) 1986-01-24
FR2566665B1 (fr) 1988-10-21
MA20467A1 (fr) 1985-12-31
SE8502876D0 (sv) 1985-06-11
GB2161074A (en) 1986-01-08
ES544565A0 (es) 1988-01-01
ATA188385A (de) 1990-07-15
FI84697B (fi) 1991-09-30
BE902732A (fr) 1985-12-24
FI852504A0 (fi) 1985-06-25
DK168191B1 (da) 1994-02-28
AT392002B (de) 1991-01-10
DK248085D0 (da) 1985-06-03
DE3523263A1 (de) 1986-01-09
IL75518A0 (en) 1985-10-31
IE58434B1 (en) 1993-09-22
AU4418785A (en) 1986-01-02
FR2566665A1 (fr) 1986-01-03
WO1986000225A1 (en) 1986-01-16
GB8515105D0 (en) 1985-07-17
IE851597L (en) 1985-12-27
NZ212301A (en) 1988-04-29
PT80707B (en) 1986-12-09
FI84697C (fi) 1992-01-10
CH668361A5 (de) 1988-12-30
AU578104B2 (en) 1988-10-13
ES8801122A1 (es) 1988-01-01
GR851575B (enrdf_load_html_response) 1985-11-25
FI852504L (fi) 1985-12-28
JPH0623108B2 (ja) 1994-03-30
JPS6140217A (ja) 1986-02-26
KR880002266B1 (ko) 1988-10-21
PH25613A (en) 1991-08-08
ZW9585A1 (en) 1985-11-13
GB2161074B (en) 1988-04-07
IT1209961B (it) 1989-08-30
SE8502876L (sv) 1985-12-28
IT8548226A0 (it) 1985-06-17
KR860000070A (ko) 1986-01-25
PT80707A (en) 1985-07-01

Similar Documents

Publication Publication Date Title
JP4700808B2 (ja) フルボ酸、および種々の状態の処置におけるその使用
JP2004506657A (ja) 天然および合成ｈｃａのバイオアベイラブルな組成物
WO1999059561A2 (en) Resveratrol inhibition of myeloperoxidase
EP0336851A1 (fr) Composition pharmaceutique pour administration orale à base d'un dérivé d'acide diphosphonique
MC1672A1 (fr) Composition pour inhiber le developpement des tumeurs a base d'un derive d'acide peroxydiphosphorique
US4975423A (en) Inhibition of tumor development
JPS58206524A (ja) 抗腫瘍剤
BE1011077A3 (fr) Composition pharmaceutique, cosmetique et/ou alimentaire aux proprietes anti-oxydantes.
EP4313155A1 (fr) Formulation par voie orale d'ivermectine et utilisations
CA2669871A1 (fr) Composition terpenique anti-microorganisme
FR2586351A1 (fr) Composition pharmaceutique a base de peroxodiphosphate pour l'inactivation d'endotoxines bacteriennes
EP0797444A1 (fr) Trousse pour cycle de traitement de l'osteoporose
WO1992022305A1 (fr) Composition therapeutique pour liberation prolongee de magnesium
CA1259259A (en) Inhibition of tumor developement
FR2600892A1 (fr) Utilisation du fructose-1,6-diphosphate pour la preparation d'une composition pharmaceutique pour la protection contre la toxicite induite par l'administration d'anthracyclines et compositions correspondantes
CA1255600A (fr) Compositions pharmaceutiques contenant comme ingredient actif l'acetyl-10 triacetoxy-1,8,9 anthracene
EP0308349A1 (fr) Nouveau derivé de choline, son procédé de préparation et nouveaux médicaments le contenant
FR2632523A1 (fr) Utilisation d'un extrait obtenu a partir d'une plante de la famille des resedacees, comme les resedas, pour la fabrication d'un medicament a activite antalgique ou analgesique et procede de fabrication d'un tel medicament
FR2842425A1 (fr) Utilisation d'extraits de ginkgo biloba pour favoriser la masse musculaire au detriment de la masse graisseuse
JPS59137414A (ja) 動脈硬化性疾患防止剤
FR2586350A1 (fr) Composition pharmaceutique a base de peroxodiphosphate pour l'inhibition de la secretion d'hormone parathyroidienne
FR2585573A1 (fr) Medicament pour prevenir l'abus d'alcool
JPH1129491A (ja) ヘリコバクター・ピロリ菌感染症治療剤
FR2805164A1 (fr) Medicaments contre l'atherosclerose a base de composes derives de chromone
JPS58208224A (ja) 抗腫瘍剤

Legal Events

Date Code Title Description
YP Annual fee paid